This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Genentech, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Eugene Yu-Chuan Chiang
Introduction
Eugene Yu-Chuan Chiang is a notable inventor based in Menlo Park, CA. He has made significant contributions to the field of biotechnology, particularly in the development of anti-CD8 antibodies. His work has implications for cancer treatment and monitoring.
Latest Patents
Eugene Yu-Chuan Chiang holds a patent for "Anti-CD8 antibodies and uses thereof." This patent includes anti-CD8 antibodies that bind to human CD8 without stimulating or inhibiting the activation of CD8 T cells. Additionally, it covers nucleic acids encoding these antibodies, vectors that contain such nucleic acids, and host cells that comprise them. The patent also details methods for using these antibodies to detect CD8 T cells in subjects, monitor disease progression in cancer patients, and track treatment progress.
Career Highlights
Eugene is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Yvonne M Chen and Jane Louise Grogan, who contribute to the collaborative environment at Genentech.
Conclusion
Eugene Yu-Chuan Chiang's contributions to the field of biotechnology, particularly through his patent on anti-CD8 antibodies, highlight his role as an innovator in cancer treatment. His work continues to influence advancements in medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile